Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasmsHideki Makishima, Jaroslaw P. Maciejewski, Pramila Krishnamurthy et al.|Blood|2022Cited by 142
Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cellsSeiichi Okabe, Kazuma Ohyashiki|Cancer Cell International|2013Cited by 21
Effect of the extracellular component of bone marrow mesenchymal stromal cells from healthy donors on hematologic neoplasms and their angiogenesisNina Gladkova, Kazuma Ohyashiki|Human Cell|2020Cited by 11
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cellsSeiichi Okabe, Kazuma Ohyashiki|Oncotarget|2018Cited by 9